Functional and anatomic response of the retina and the choroid to intravitreal bevacizumab for macular edema

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 1, 2012, Pages 69-75

  Forte, Raimondo ^a   Cennamo, Gilda ^a   Breve, Maria Angelica ^a   Vecchio, Elisabetta Chiariello ^a   De Crecchio, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CHOROID; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; RETINA; RETINA MACULA EDEMA; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROID; CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84856833947     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2010.0181     Document Type: Article

References (24)

1. Ferrara, N. Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77:527-543, 1999. (Pubitemid 29426311)
2. Noma, H., Funatsu, H., Yamasaki, M., Tsukamoto, H., Mi-mura, T, Sone, T, Jian, K., Sakamoto, I., Nakano, K., Yama-shita, H., Minamoto, A., and Mishima, H.K. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am. J. Ophthalmol. 140:256-261, 2005.
3. Shimada, H., Akaza, E., Yuzawa, M., and Kawashima, M. Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema. Invest Ophthalmol. Vis. Sci. 50:2953-2955, 2009.
4. Yannuzzi, L.A., Negrao, S., Iida, T., Carvalho, C., Rodriguez-Coleman, H., Slakter, J., Freund, K.B., Sorenson, J., Orlock, D, and Borodoker, N. Retinal angiomatous proliferation in age-related macular degeneration. Retina 21:416-434, 2001. (Pubitemid 32971350)
5. Haritoglou, C., Kook, D., Neubauer, A., Wolf, A., Priglinger, S., Strauss, R., Gandorfer, A., Ulbig, M., Kampik, A. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26:999-1005, 2006. (Pubitemid 44973218)
6. Iturralde, D., Spaide, R.F., Meyerle, C.B., Klancnik J.M., Yannuzzi, L.A., Fisher, Y.L., Sorenson, J., Slakter, J.S., Freund, K.B., Cooney, M, and Fine, H.F. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: A short-term study. Retina 26:279-284, 2006. (Pubitemid 44318180)
7. Gharbiya, M., Allievi, F., Recupero, V., Martini, D., Mazzeo, L., and Gabrieli, C.B. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: Twelvemonth results. Retina 29:740-749, 2009.
8. Wu, L., Arevalo, J.F., Berrocal, M.H., Maia, M., Roca, J.A., Morales-Cantón, V., Alezzandrini, A.A., and Díaz-Llopis, M.J. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: Results of the Pan American Collaborative Retina Study Group at 24 months. Retina 29:1396-1403, 2009.
9. Spaide, R.F., Laud, K., Fine, H.F., Klancnik J.M., Meyerle, C.B., Yannuzzi, L.A., Sorenson, J., Slakter, J., Fisher, Y.L., and Cooney, M.J. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related mac-ular degeneration. Retina 26:383-390, 2006. (Pubitemid 44197628)
10. Welch, D.E., Elmariah, H., Peden, M.C., Adams, S.G., Rat-nakaram, R., and Kaushal, S. Short-term response of macular edema to intravitreal bevacizumab. Br. J. Ophthalmol. 93: 1033-1036, 2009.
11. Cennamo, G., Rosa, N., La Rana, A., Pasquariello, A., and Iaccarino, G. Macula study with standardized echography. Acta Ophthalmol. Scand. 74:178-181, 1996. (Pubitemid 26146625)
12. Aiello, L.P., Brucker, A.J., Chang, S., Cunningham, E.T., Jr., D'Amico, D.J., Flynn, H.W., Jr., Grillone, L.R., Hutcherson, S., Liebmann, J.M., O'Brien, T.P., Scott, I.U., Spaide, R.F., Ta, C., and Trese, M.T. Evolving guidelines for intravitreous injections. Retina 24:13-19, 2004.
13. Fujii, G.Y., De Juan, E., Humayun, M.S., Sunness, J.S., Chang, T.S., and Rossi, J.V. Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am. J. Ophthalmol. 136:1067-1078, 2003. (Pubitemid 37485773)
14. Forte, R., Cennamo, G.L., Finelli, M.L., de Crecchio, G. Comparison of time domain Stratus OCT and spectral domain SLO/OCT for assessment of macular thickness and volume. Eye (Lond.) 23:2071-2078, 2009.
15. Atta, H.R., and Byrne, S.F. The findings of standardized echography for choroidal folds. Arch. Ophthalmol. 106:1234-1241, 1988.
16. Bashshur, Z.F., Haddad, Z.A., Schakal, A., Jaafar R.F., Saab, M., and Noureddin, B.N. Intravitreal bevacizumab for treatment ofneovascular age-related macular degeneration:A one-year prospective study. Am. J. Ophthalmol. 145:249-256, 2008.
17. Kriechbaum, K., Michels, S., Prager, F., Georgopoulos, M., Funk, M., Geitzebnauer, W., and Schmidt-Erfurth, U. In-travitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br. J. Ophthalmol. 92: 518-522, 2008. (Pubitemid 351497981)
18. Ferrara, D.C., Koizumi, H., and Spaide, R.F. Early bev-acizumab treatment of central retinal vein occlusion. Am. J. Ophthalmol. 144:864-871, 2007. (Pubitemid 350122344)
19. Schaal, S., Kaplan, H.J., and Tezel, T.H. Is there tachyphy-laxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration? Ophthalmology 115:2199-2205, 2008.
20. Yamaike, N., Tsujikawa, A., Sakamoto, A., Ota, M., Kotera, Y., Miyamoto, K., Kita, M., and Yoshimura, N. Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Retina 29:757-767, 2009.
21. Carpineto, P., Ciancaglini, M., Di Antonio, L., Gavalas, C., and Mastropasqua, L. Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema. Retina 27:21-29, 2007. (Pubitemid 46095826)
22. Kube, T., Schmidt, S., Toonen, F., Kirchhof, B., and Wolf, S. Fixation stability and macular light sensitivity in patients with diabetic maculopathy: A microperimetric study with a scanning laser ophthalmoscope. Ophthalmologica 219:16-20, 2005. (Pubitemid 40091385)
23. Ladewig, M.S., Karl, S.E., Hamelmann, V., Helb, H-M., Scholl, H.P.N., Holz, F.G., and Eter, N. Combined intra-vitreal bevacizumab and photodynamic therapy for neo-vascular age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 246:17-25, 2008. (Pubitemid 350162680)
24. Koch, K.R., Muether, P.S., Hermann, M.M., Hoerster, R., Kirchhof, B., and Fauser, S. Subjective perception versus objective outcome after intravitreal ranibizumab for exudative AMD. Graefes Arch Clin Exp Ophthalmol. 2011 Sep 8. [epub ahead of print].